Marvell Technology is running two stories at the same time, and right now the market is only pricing one of them. MRVL closed Friday at $141.20, down roughly 25% from its late-October high, after the company announced a $115 billion all-stock acquisition of optical components maker Lumentum on November 2. That single session cost shareholders 12.7%, with MRVL closing at $171.41. The stock has not recovered. Meanwhile, the underlying business is accelerating at a pace that makes the sell-off worth examining carefully.
The Numbers Behind the Drop
Q2 fiscal 2027 revenue came in at $2.739 billion, a new record, growing 37% year-on-year and landing $39 million above the midpoint of guidance. Data center revenue hit $2.172 billion, 79% of total revenue, up 46% year-over-year. Non-GAAP EPS of $0.94 beat consensus by roughly a penny. What matters more for traders right now is what management said about Q3: third quarter fiscal 2027 revenue guidance stands at $3.15 billion, plus or minus 5%, implying more than 50% year-over-year growth. Full-year fiscal 2027 revenue outlook was raised to approximately $12 billion, roughly 45% growth, while fiscal 2028 was lifted to approximately $18 billion, a $1.5 billion raise quarter-over-quarter.
Those are not soft numbers. The question is whether the Lumentum deal changes the calculus enough to justify a 25% compression against that backdrop.
The Lumentum Variable
Announced November 2, the all-stock transaction values Lumentum at an enterprise value of $115 billion, with Lumentum stockholders receiving 4.5 Marvell shares per share held, a 23.9% premium to the October 28 unaffected close. Post-closing, current Marvell stockholders will own approximately 67% of the combined company. The merger is subject to shareholder and regulatory approvals, with completion expected in the first half of 2028. Until then, the dilution is priced in but the synergies are not.
The companies project combined total addressable market of $550 billion and expect more than $1 billion in annual run-rate cost synergies, with the deal expected to add to Marvell’s non-GAAP EPS in the first year after closing. Nvidia’s $2 billion investment in Lumentum would convert into Marvell shares, consolidating two large bets into one holding. Strategically, the logic is coherent: AI clusters need tighter electrical-optical co-design, and Marvell’s existing electro-optics portfolio, anchored by its 2nm optical interconnect demonstrations at ECOC 2026, points directly at that bottleneck. The market’s reaction is about dilution math and deal execution risk, not the thesis itself.
Technical Structure and Key Levels
MRVL is trading near $141.20, below its short- and medium-term moving averages, with momentum still negative. On November 3, RBC Capital cut its target from $425 to $250 while keeping Outperform; B. Riley trimmed from $365 to $275 maintaining Buy; Needham reduced from $400 to $300 holding Buy. Across 44 analysts, the consensus remains Strong Buy with an average target of about $310.
The $135 zone represents the first meaningful support band visible in options positioning. A close above $155 would shift the near-term structure from distribution back toward accumulation. Volume patterns since the deal announcement show elevated selling, but no acceleration, which suggests forced liquidation rather than fundamental repositioning by institutional holders.
Scenario Modeling
Bull Case: Q3 earnings in early December deliver revenue at or above $3.3 billion, Lumentum synergy details sharpen, and the combined TAM framing gains traction. MRVL recaptures $175 to $185 within 30 days of the report.
Base Case: Q3 comes in line near $3.15 billion with non-GAAP EPS around $1.10 guidance. The stock stabilizes in the $145 to $160 range as deal noise fades and the custom silicon ramp continues. Marvell flagged a significant acceleration in its custom business beginning in the second half of fiscal 2027, which Q3 results will either confirm or undercut.
Bear Case: Any Q3 guidance miss, margin compression below 57.5% non-GAAP, or regulatory friction on the Lumentum deal pushes MRVL below $125, the next identifiable structural support.
Active Trader Framework
The next earnings date is the pivotal event, but as of November 8, 2026, Marvell has not confirmed an exact publication date for Q3 fiscal 2027 results. Traders sizing MRVL here are carrying deal-dilution risk, macro semiconductor risk, and execution risk across the window before that catalyst resolves. Position sizing should reflect all three. A vol-defined approach, risk bounded at the $129 level, keeps the downside quantified while leaving exposure to what could be a sharp reversal if Q3 matches the trajectory management has consistently guided toward. Guidance has beaten midpoint in every quarter of fiscal 2027 so far. That streak either continues in the next report, or the entire fundamental case gets repriced.
Preparation here means understanding exactly which metric moves the stock: data center revenue growth rate and custom silicon commentary, not headline EPS. Watch those two lines first.
